Fibioseq Medical

Company Overview

Snapshot

Founded in February 2017 by Harel Manor and Lauren Gorelick, Fibioseq Medical operates with 1–10 employees. The company has raised $1.73 million across four funding rounds, with Founders as an investor. In January 2020, Fibioseq Medical secured a grant from the Israel Innovation Authority.

Business overview

Fibioseq Medical is a development-stage company specializing in wrist joint replacement solutions within the Health Tech & Life Sciences sector. The company's core product, WristArt, is a patented Total Wrist Arthroplasty implant designed to improve patient care by preserving natural joint biomechanics and providing near-normal range of motion. WristArt features a double center of rotation and aims to simplify surgical procedures while maintaining critical blood flow. Fibioseq Medical serves the medical devices industry, targeting surgeons and patients globally with its minimally-invasive bone treatment technologies.

Company Intelligence Q&A

What is Fibioseq Medical's primary focus?

Fibioseq Medical is focused on developing advanced wrist joint replacement solutions to enhance patient care in the field of total wrist implants.

Who founded Fibioseq Medical?

Fibioseq Medical was co-founded by Harel Manor and Lauren Gorelick in February 2017.

What is the WristArt implant?

WristArt is Fibioseq Medical's patented Total Wrist Arthroplasty implant, designed to preserve natural joint biomechanics and provide near-normal range of motion for patients, while simplifying procedures for surgeons.

Has Fibioseq Medical received any grants?

Yes, Fibioseq Medical secured a grant from the Israel Innovation Authority in January 2020 and another in April 2018.

What is the current stage of Fibioseq Medical's product development?

Fibioseq Medical's WristArt product is currently in the clinical trial stage, aiming to improve on existing solutions by preserving natural joint biomechanics and providing near-normal range of motion for patients.